Blood eosinophilia, use of inhaled corticosteroids, and risk of COPD exacerbations and mortality

PURPOSE: It remains unclear whether eosinophilia is useful for in guiding inhaled corticosteroid (ICS) therapy in chronic obstructive pulmonary disease (COPD) patients. The goal of this study is to evaluate the risk of acute exacerbations, COPD‐related hospitalisations/accident and emergency visits,...

Descripción completa

Detalles Bibliográficos
Autores principales: Oshagbemi, Olorunfemi A., Franssen, Frits M.E., Braeken, Dionne C.W., Henskens, Yvonne, Wouters, Emiel F.M., Maitland‐van der Zee, Anke‐Hilse, Burden, Andrea M., de Vries, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282838/
https://www.ncbi.nlm.nih.gov/pubmed/30264901
http://dx.doi.org/10.1002/pds.4655

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282838/
https://www.ncbi.nlm.nih.gov/pubmed/30264901
http://dx.doi.org/10.1002/pds.4655

Ejemplares similares